Found: 66
Select item for more details and to access through your institution.
Unravelling the role of PLK1 in tumorigenesis by revealing the mutational landscape of colorectal and lung cancer with PLK1 mutations.
- Published in:
- Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 12, p. 1, doi. 10.1111/jcmm.18497
- By:
- Publication type:
- Article
Clinical homologous recombination repair gene reversion analysis identifies mechanisms of resistance to PARP inhibitors and platinum‐chemotherapy.
- Published in:
- Medcomm: Oncology, 2024, v. 3, n. 2, p. 1, doi. 10.1002/mog2.79
- By:
- Publication type:
- Article
Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real‐world cohort analysis.
- Published in:
- Journal of Pathology: Clinical Research, 2024, v. 10, n. 3, p. 1, doi. 10.1002/2056-4538.12375
- By:
- Publication type:
- Article
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01320-9
- By:
- Publication type:
- Article
Pathologic nodal metastasis assessment using tumour‐derived molecular features in patients with lung adenocarcinoma.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 4, p. 1, doi. 10.1002/ctm2.1638
- By:
- Publication type:
- Article
Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice.
- Published in:
- Infection, 2024, v. 52, n. 2, p. 625, doi. 10.1007/s15010-024-02185-1
- By:
- Publication type:
- Article
Higher 13‐Gene‐Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T‐Cell Lymphoma Patients.
- Published in:
- Advanced Biology, 2023, v. 7, n. 12, p. 1, doi. 10.1002/adbi.202300042
- By:
- Publication type:
- Article
The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04634-1
- By:
- Publication type:
- Article
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 4999, doi. 10.3390/cancers15204999
- By:
- Publication type:
- Article
Lineage tracing for multiple lung cancer by spatiotemporal heterogeneity using a multi-omics analysis method integrating genomic, transcriptomic, and immune-related features.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1237308
- By:
- Publication type:
- Article
Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2675, doi. 10.1007/s10238-023-01018-z
- By:
- Publication type:
- Article
Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 10, p. 1, doi. 10.1002/ctm2.1430
- By:
- Publication type:
- Article
Simultaneous diagnosis of tuberculous pleurisy and malignant pleural effusion using metagenomic next-generation sequencing (mNGS).
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04492-x
- By:
- Publication type:
- Article
Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1150098
- By:
- Publication type:
- Article
Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.
- Published in:
- Cancer Science, 2023, v. 114, n. 7, p. 2774, doi. 10.1111/cas.15804
- By:
- Publication type:
- Article
Genomic features, evolutionary patterns and minimal residual disease at surgical margins as novel prognostic/predictive biomarkers in locally advanced rectal cancer.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 6, p. 1, doi. 10.1002/ctm2.1286
- By:
- Publication type:
- Article
Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04077-8
- By:
- Publication type:
- Article
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1261, doi. 10.1007/s00262-022-03330-1
- By:
- Publication type:
- Article
Pan‐cancer molecular analysis of EGFR large fragment deletion in the Asian population.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8083, doi. 10.1002/cam4.5603
- By:
- Publication type:
- Article
Utilizing Metagenomic Next-Generation Sequencing (mNGS) for Rapid Pathogen Identification and to Inform Clinical Decision-Making: Results from a Large Real-World Cohort.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 4, p. 1175, doi. 10.1007/s40121-023-00790-5
- By:
- Publication type:
- Article
Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 6009, doi. 10.1002/cam4.5325
- By:
- Publication type:
- Article
Early diagnosis of brain metastases using cerebrospinal fluid cell‐free DNA‐based breakpoint motif and mutational features in lung cancer.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 3, p. 1, doi. 10.1002/ctm2.1221
- By:
- Publication type:
- Article
Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02768-z
- By:
- Publication type:
- Article
The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-022-00443-8
- By:
- Publication type:
- Article
Correction: Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1000146
- By:
- Publication type:
- Article
Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 20, p. 3689, doi. 10.1002/1878-0261.13297
- By:
- Publication type:
- Article
Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1209, doi. 10.4143/crt.2021.963
- By:
- Publication type:
- Article
RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Neoadjuvant ceritinib treatment in ALK‐rearranged locally advanced adenosquamous carcinoma: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 15, p. 2275, doi. 10.1111/1759-7714.14558
- By:
- Publication type:
- Article
Uterine perivascular epithelioid tumors (PEComas) with lung metastasis showed good responses to mTOR and VEGFR inhibitors: A case report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.797275
- By:
- Publication type:
- Article
NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 13, p. 2541, doi. 10.1002/cam4.4561
- By:
- Publication type:
- Article
Long-Term Clinical Benefit in EGFR -Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
The clinical utility of dynamic ctDNA monitoring in inoperable localized NSCLC patients.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01590-0
- By:
- Publication type:
- Article
Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 5, p. 1, doi. 10.1002/ctm2.847
- By:
- Publication type:
- Article
Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/1763778
- By:
- Publication type:
- Article
Poor prognosis of intra‐tumoural TRBV6‐6 variants in EGFR‐mutant NSCLC: Results from the ADJUVANT‐CTONG1104 trial.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.775
- By:
- Publication type:
- Article
Altered Signaling Pathways Revealed by Comprehensive Genomic Profiling in Patients With Unknown Primary Tumors.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 5353, doi. 10.2147/OTT.S334847
- By:
- Publication type:
- Article
Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00221-z
- By:
- Publication type:
- Article
Clearance of circulating tumor DNA in a high-risk stage-IV rectal carcinoma patient with synchronous liver metastases after conversion surgery is correlated with pathologic complete response.
- Published in:
- Therapeutic Advances in Gastrointestinal Endoscopy, 2021, p. 1, doi. 10.1177/26317745211020279
- By:
- Publication type:
- Article
Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 2, p. 490, doi. 10.20892/j.issn.2095-3941.2020.0120
- By:
- Publication type:
- Article
Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors.
- Published in:
- Cancer Communications, 2021, v. 41, n. 2, p. 183, doi. 10.1002/cac2.12128
- By:
- Publication type:
- Article
Association of circulating tumor DNA from the cerebrospinal fluid with high‐risk CNS involvement in patients with diffuse large B‐cell lymphoma.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 1, p. 1, doi. 10.1002/ctm2.236
- By:
- Publication type:
- Article
Clearance of circulating tumor DNA in a high-risk stage-IV rectal carcinoma patient with synchronous liver metastases after conversion surgery is correlated with pathologic complete response.
- Published in:
- Therapeutic Advances in Gastrointestinal Endoscopy, 2021, p. 1, doi. 10.1177/26317745211020279
- By:
- Publication type:
- Article
Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib‐based combination therapy: A real‐world experience of off‐label ibrutinib use.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8676, doi. 10.1002/cam4.3499
- By:
- Publication type:
- Article